Britons least likely to adopt protective behaviours against flu

NewsGuard 100/100 Score

A new international survey published in The Lancet Infectious Diseases has revealed that during the H1N1 influenza pandemic in 2009, people in Britain lagged far behind other countries in adopting protective behaviours, such as increasing their practice of covering their mouth with a tissue when sneezing or coughing.

Researchers questioned nearly 5000 people in Argentina, Japan, Mexico, UK, and USA about the protective habits they adopted during the 2009 H1N1 ‘swine flu’ pandemic, asking about non-pharmaceutical protective behaviours such as increased hand washing; social distancing behaviours such as avoiding hugging or kissing; and vaccination. 

Nearly three quarters (73%) of British people surveyed admitted that they did not cover their mouth or nose with a tissue more frequently when coughing or sneezing during the pandemic, and just under half (47%) of British people did not wash their hands or use hand sanitiser more frequently.

By contrast, almost four fifths (77%) of Mexicans made increased efforts to cover their mouth with a tissue when coughing and sneezing, and in all other countries surveyed, at least two thirds of people said that they washed their hands more frequently during the pandemic, with the highest proportion of respondents (89%) claiming this in Argentina.

The researchers found that uptake of non-pharmaceutical behaviours such as increasing hand washing and avoiding large gatherings did not appear to affect the uptake of vaccination, although they noted that vaccination uptake was low in all of the countries surveyed.  Mexico had the highest vaccination uptake, with a third (33%) of survey participants claiming that they had been vaccinated – in Britain, 21% of survey respondents said they had been vaccinated.

The researchers also examined whether respondents supported government recommendations to distance themselves from others in various ways or adopt additional personal protective measures during the flu pandemic.  In most countries, approval of these recommendations was fairly high, although again, Britons responded less enthusiastically, with around half of respondents saying that they would not have approved of government policies to avoid public places or wear a mask in public.

According to one of the study’s authors, Dr Gillian SteelFisher of the Harvard School of Public Health in Boston, USA, “The wide variations between countries in our study shows that in the event of another serious outbreak of infectious disease, public perceptions have to be taken into account to best tailor and communicate policy approaches that need public support in each country.” 

“Our findings suggest that promoting non-pharmaceutical interventions – such as handwashing and avoiding large public gatherings of people – do not jeopardise the adoption of vaccination, though the uptake of vaccines was low compared to other behaviours in all countries we surveyed.  To maximise the effect of pandemic policies, future efforts might need to combine vaccination programmes with support for the most effective non-pharmaceutical interventions.”

Writing in a linked Comment, Alison Holmes of Imperial College London, UK, adds that, “Providing an effective response to emerging infectious disease remains a pressing global health challenge.  Governments and international organisations have to promptly implement feasible and proportionate health protection measures, while accepting the limitations of the scientific evidence used to underpin those measures.  Establishing which protective behaviours are effective is not sufficient – we need to understand how populations make sense of recommendations and adopt them.”

Comments

  1. Gord5467 Gord5467 Canada says:

    I was with the Canadian Forces in 2009, was ordered to get the H1N1 shot (AREPANRIX by GSK GlaxoSmithKline) and had an adverse reaction to the vaccine.  I received PERMANENT neurological, cardiovascular, gastrointestinal, and respiratory symptoms: dizziness, vertigo, irregular heart rhythms, shortness of breath, muscle weakness and pain, and numbness in hands and feet. My physical fitness changed from special forces fit to that of a 70 year old in a matter of days.  Prior to the vaccination the Department of National Defence (DND) provided information advising side effects "having mild chills and fever a few days following the shot means it is working", and "There is a 1 in 1,000,000 chance of acquiring a serious neurological complication".  According to GSKs product information provided by Health Canada, "neurological disorders" are "very rare (may occur with up to 1 in 10,000 doses)" and "if any of these side effects occur, please tell your doctor or nurse immediately" which differs from the information provided to soldiers.  The DND also stated "It is not a live vaccine so it cannot give you the flu".  According to Dr. Danuta Skowronski, an epidemiologist and an influenza expert at the B.C. Centre for Disease Control, "In the early weeks of the pandemic that people who got the flu shot (H1N1) for 2008-09 winter seemed to be more likely to get infected with the pandemic virus than people who hadn't received the shot".  Another study linked narcolepsy, a neurological disorders to the H1N1 vaccine,  "Narcolepsy in association with pandemic influenza vaccination", September 2012, European Centre for Disease Prevention and Control.  You may also query the National Vaccine Information Center database of adverse reactions to vaccines (VAERS) which includes more than 11,465 events (adverse reactions) to the H1N1 vaccine, 3,390 symptoms and 61,500 reactions (more than 5 reactions per record).  In the UK, the "FINAL PUBLIC SUMMARY - UK Suspected Adverse Reaction Analysis, Swine Flu (H1N1) Vaccines - Celevanpan and Pandemrix, 26 March 2010" details more than 8,600 suspected reactions classified into 650 reaction names.  Other information to consider is from Richard Warrington, President of the Canadian Society of Allergy and Clinical Immunology, "Vaccination with Arepanrix has led to far more reports of anaphylaxis or significant allergic reactions than is normally expected for a flu vaccine."  You may also ask your doctor and other Health care workers if they received the H1N1 vaccination and if they plan to remain up to date with all vaccinations.  Reports from Canada, US, India, Hong Kong and other countries note a 50% vaccination rate among those who recommend and administer the immunization.  According to Fox News "Most said they would pass on the H1N1 shot ... because they were afraid of side effects and doubted how safe and effective it would be."  I asked my doctor and he didn't hesitate in saying "no way".  Be informed and please choose wisely if you do plan to have your next flu shot or vaccination.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Fluid-filled lung sac found to be the hub for virus-eating cells